Breast Cancer Clinical Trial

Sensation After Nipple Sparing Mastectomy and Breast Reconstruction With or Without Neurotized Free Tissue Transfer

Summary

Tissue Expander/Implant Reconstruction: The purpose of this study is to determine how and when nerve sensation to the breast skin returns after mastectomy.

Autologous Tissue Reconstruction: The purpose of this study is to determine whether the tissue being used to reconstruct your breast can provide sensation by using your own nerves. Typically all sensation is lost immediately after this type of surgery and returns to varying degrees. We are hoping to demonstrate that by connecting the two nerves (one from abdomen and one from the chest wall) together, we can attain meaningful sensation in the transferred tissues thereby improving your quality of life following surgery.

View Full Description

Full Description

To determine the timing and distribution of sensation recovery of breast after mastectomy and breast reconstruction, both with autologous and implant-based reconstruction. Also, to determine the role of innervated free tissue transfer in breast reconstruction.

Specific Aims

Determine the timing and degree of return of breast in women who underwent mastectomy with autologous tissue or with implant based reconstruction.
Determine sensation following neurotized free flap reconstruction
Determine whether neurotization has an impact on quality of life measures post operatively

Study Design Patients will be enrolled prospectively in this data collection study in which they will receive the standard of care for breast cancer resection and oncologically safe and accepted means of breast reconstruction with tissue expander and/or prosthetic implants. Patients will receive additional, non-invasive sensory testing, performed at standard follow up intervals in clinic by their reconstructive team. All patients participating in the study will be consented for enrollment at the pre-operative visit by either the surgeon or physician assistant. As this is a prospective study, all women fitting inclusion criteria over a 6-month minimal, but projected goal 12-month period will be included.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients undergoing unilateral or bilateral skin sparing mastectomy for breast cancer

Patient must have one of the following reconstructions in planned:

Immediate tissue expander placement
Immediate implant placement
Immediate autologous breast reconstruction
All patients participating in the study must be willing to be consented for enrollment at the pre-operative visit.

Exclusion Criteria:

Pre-operative radiation therapy
Any pre-excising
Patients with absent or prior damaged nipple areola-complex (NAC) on the "non-surgical breast"

Study is for people with:

Breast Cancer

Study ID:

NCT03135392

Recruitment Status:

Withdrawn

Sponsor:

Case Comprehensive Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Cleveland Clinic, Case Comprehensive Cancer Center
Cleveland Ohio, 44195, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Study ID:

NCT03135392

Recruitment Status:

Withdrawn

Sponsor:


Case Comprehensive Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider